.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
AstraZeneca
Cerilliant
US Army
Accenture
Express Scripts
Dow
Boehringer Ingelheim
Covington

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206494

« Back to Dashboard

NDA 206494 describes AVYCAZ, which is a drug marketed by Cerexa and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug. Additional details are available on the AVYCAZ profile page.

The generic ingredient in AVYCAZ is avibactam sodium; ceftazidime. One supplier is listed for this compound. Additional details are available on the avibactam sodium; ceftazidime profile page.

Summary for 206494

Tradename:1
Applicant:1
Ingredient:1
Patents:8
Formulation / Manufacturing:see details

Pharmacology for NDA: 206494

Ingredient-typeCephalosporins
Mechanism of Actionbeta Lactamase Inhibitors

Suppliers and Packaging for NDA: 206494

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AVYCAZ avibactam sodium; ceftazidime POWDER;IV (INFUSION) 206494 NDA Allergan, Inc. 0456-2700 0456-2700-10 10 VIAL, SINGLE-USE in 1 CARTON (0456-2700-10) > 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE (0456-2700-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;IV (INFUSION)StrengthEQ 0.5GM BASE;2GM/VIAL
Approval Date:Feb 25, 2015TE:RLD:Yes
Patent:► SubscribePatent Expiration:Feb 24, 2022Product Flag?YSubstance Flag?YDelist Request?
Patented Use:METHOD OF TREATING BACTERIAL INFECTIONS
Patent:► SubscribePatent Expiration:Nov 12, 2026Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Jul 24, 2021Product Flag?YSubstance Flag?YDelist Request?
Patented Use:METHOD OF TREATING BACTERIAL INFECTIONS


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Teva
Moodys
Queensland Health
Cantor Fitzgerald
Novartis
US Army
Harvard Business School
Dow
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot